Literature DB >> 20578014

Vital signs and cognitive function are not affected by 23-sodium and 17-oxygen magnetic resonance imaging of the human brain at 9.4 T.

Ian C Atkinson1, Rachel Sonstegaard, Neil H Pliskin, Keith R Thulborn.   

Abstract

PURPOSE: To evaluate the effect of 23-sodium ((23)Na) and 17-oxygen ((17)O) magnetic resonance imaging (MRI) at 9.4 (T) on vital signs and cognitive function of the human brain.
MATERIALS AND METHODS: Vital sign and cognitive function measurements from healthy volunteers (N = 14) positioned outside and at isocenter of a 9.4 T scanner before and after (23)Na and (17)O MRI were compared for changes due to exposure to the static magnetic field and to the gradient switching and radiofrequency radiation during MRI.
RESULTS: Exposure to the 9.4 T static magnetic field and (23)Na and (17)O MRI at 105.92 MHz and 54.25 MHz, respectively, did not have a statistically significant (P > 0.05) effect on the vital signs or cognitive function of healthy normal adults.
CONCLUSION: (23)Na and (17)O MRI of the human brain at 9.4 T does not have any readily demonstrated health risks reflected in vital signs or change in cognitive performance. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20578014     DOI: 10.1002/jmri.22221

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  17 in total

1.  Review. The Agfa Mayneord lecture: MRI of short and ultrashort T₂ and T₂* components of tissues, fluids and materials using clinical systems.

Authors:  G M Bydder
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

2.  MR safety: simultaneous B0, dΦ/dt, and dB/dt measurements on MR-workers up to 7 T.

Authors:  Jens Groebner; Reiner Umathum; Michael Bock; Axel J Krafft; Wolfhard Semmler; Jaane Rauschenberg
Journal:  MAGMA       Date:  2011-07-14       Impact factor: 2.310

Review 3.  Measurement techniques for magnetic resonance imaging of fast relaxing nuclei.

Authors:  Simon Konstandin; Armin M Nagel
Journal:  MAGMA       Date:  2013-07-24       Impact factor: 2.310

4.  Sodium MRI in a rat migraine model and a NEURON simulation study support a role for sodium in migraine.

Authors:  Michael G Harrington; Eduard Y Chekmenev; Victor Schepkin; Alfred N Fonteh; Xianghong Arakaki
Journal:  Cephalalgia       Date:  2011-08-04       Impact factor: 6.292

5.  Sodium 3D COncentration MApping (COMA 3D) using (23)Na and proton MRI.

Authors:  Milton L Truong; Michael G Harrington; Victor D Schepkin; Eduard Y Chekmenev
Journal:  J Magn Reson       Date:  2014-09-09       Impact factor: 2.229

6.  Electrodynamics and radiofrequency antenna concepts for human magnetic resonance at 23.5 T (1 GHz) and beyond.

Authors:  Lukas Winter; Thoralf Niendorf
Journal:  MAGMA       Date:  2016-04-20       Impact factor: 2.310

7.  Clinically constrained optimization of flexTPI acquisition parameters for the tissue sodium concentration bioscale.

Authors:  Ian C Atkinson; Aiming Lu; Keith R Thulborn
Journal:  Magn Reson Med       Date:  2011-03-28       Impact factor: 4.668

8.  In vivo magnetic resonance imaging of sodium and diffusion in rat glioma at 21.1 T.

Authors:  Victor D Schepkin; Fabian Calixto Bejarano; Thomas Morgan; Shannon Gower-Winter; Manuel Ozambela; Cathy W Levenson
Journal:  Magn Reson Med       Date:  2011-07-11       Impact factor: 4.668

9.  Behavioral effects on rats of motion within a high static magnetic field.

Authors:  Thomas A Houpt; Lee Carella; Dani Gonzalez; Ilana Janowitz; Anthony Mueller; Kathleen Mueller; Bryan Neth; James C Smith
Journal:  Physiol Behav       Date:  2010-11-28

Review 10.  Toward 20 T magnetic resonance for human brain studies: opportunities for discovery and neuroscience rationale.

Authors:  Thomas F Budinger; Mark D Bird; Lucio Frydman; Joanna R Long; Thomas H Mareci; William D Rooney; Bruce Rosen; John F Schenck; Victor D Schepkin; A Dean Sherry; Daniel K Sodickson; Charles S Springer; Keith R Thulborn; Kamil Uğurbil; Lawrence L Wald
Journal:  MAGMA       Date:  2016-05-18       Impact factor: 2.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.